CompletedNot Applicable

Effects of FDA Authorized Smokeless Tobacco Claims Among US Adults Who Smoke Cigarettes

United States1,257 participantsStarted 2025-04-24

Plain-language summary

This study will be an online survey experiment conducted with adults who smoke cigarettes (ages 21+) to examine their reactions to modified risk advertising claims authorized by the Food \& Drug Administration (FDA) for two smokeless tobacco brands (General Snus and Copenhagen), which describe the lower risks of these products compared to cigarette smoking. The study will compare effects of ads with different two different claim types (i.e. claims about reduced lung cancer risk and claims about reduced risks for multiple disease) versus ads with no reduced-risk claims, and examine effects on message and product perceptions, and interest in using the smokeless tobacco products. This study will also examine how smokers' reactions/interest may vary based on the product brand, and asses prior awareness/exposure to the authorized claims.

Who can participate

Age range

21 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults (age 21 and over) who are current established cigarettes smokers (i.e., smoked 100 cigarettes in their lifetime and now smoke every day or somedays), based in the US, members of Ipsos' KnowledgePanel, and have chosen to complete their research panel surveys in English Exclusion Criteria: * Panel participants who do not meet the criteria outlined above will be excluded.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

General Relative Harm Perception

Timeframe: Assessed in survey measures completed immediately after viewing the study stimuli

Perceptions of Perceived Relative Risks of Diseases

Timeframe: Assessed in survey measures completed immediately after viewing the study stimuli

Absolute Harm Perception

Timeframe: Assessed in survey measures completed immediately after viewing the study stimuli

Product Use Intentions

Timeframe: Assessed in survey measures completed immediately after viewing the study stimuli

Trial details

NCT IDNCT06927700

SponsorRutgers, The State University of New Jersey

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-04

Results submitted2026-02-11

View on ClinicalTrials.gov More Tobacco Product Beliefs and Use trials

Plain-language summary

Who can participate

Age range

21 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

General Relative Harm Perception

Timeframe: Assessed in survey measures completed immediately after viewing the study stimuli

Perceptions of Perceived Relative Risks of Diseases

Timeframe: Assessed in survey measures completed immediately after viewing the study stimuli

Absolute Harm Perception

Timeframe: Assessed in survey measures completed immediately after viewing the study stimuli

Product Use Intentions

Timeframe: Assessed in survey measures completed immediately after viewing the study stimuli